bachem semaglutide Semaglutide! What is it, and how does it work? #glp #obesity #diabetes #peptides #genericdrugs

Epub 2019 Apr 8

On balance, the beneficial associations for GLP-1 drugs were stronger, more numerous, and generally related to more serious health outcomes than the negative associations

The Basics at a Glance Generic name: Retatrutide (development code: LY3437943) Manufacturer: Eli Lilly and Company Drug class: Triple agonist (GLP-1/GIP/glucagon receptor agonist) Administration: Once-weekly subcutaneous injection Dosing range: 2mg to 12mg weekly (gradual titration over 12+ weeks) Half-life: Approximately 6 days (reaches steady state in 45 weeks) FDA status: Phase 3 clinical trials (TRIUMPH program) Expected approval: 20272028 How Retatrutide Differs from Other GLP-1 Medications To understand retatrutide, it helps to see where it fits in the evolution of GLP-1 class medications

What happens if I miss a dose of BPC 157